BLUE

bluebird bio, Inc.

Healthcare

Set alert

Price alert · BLUE

All alert types
4.97 0.00 0.00%
As of Jun 2, 2025
4.97 Day range 4.97

52-week range unavailable

YTD
-40.41%
1 year
-72.25%
Open
4.97
Prev close
4.97
Mkt cap
75.74M
Vol
1.25M
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
4.97
High
4.97
Forward P/E
-11.98
Beta
0.80
Short ratio
9.53
Inst. own
43.69%
Dividend
0.00
Ex-div date
50-d avg
8.54
200-d avg
16.13
1y target
37.71

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for BLUE has not been loaded yet. Try again in a moment.

Discussion (235)

Sign in to join the discussion

Lawrence Mcdonald BLUE 2 years ago #2

I haven’t seen this kind of manipulation since Trump brain washed 1/2 of Americans

Lawrence Mcdonald BLUE 2 years ago #3

EDIT is 3x the market cap with 2 drugs in phase 2-3 for drugs we already have approved. They have 270 mil cash and 30 million in debt and their other candidates are preclinical. Go figure

Lawrence Mcdonald BLUE 2 years ago #5

Biotech is a broken market and that’s why value doesn’t even matter anymore. We are adrift in a rudderless ship.

Lawrence Mcdonald BLUE 2 years ago #6

The only rub here is most institutional will have to dump this based on stock price?

Lawrence Mcdonald BLUE 2 years ago #9

Theoretically it could go to 0 on 100k share volume and still have all its assets and promise